Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Screening For Anti-Leukemic CTLs After Allogeneic Hematopoietic Stem Cell Transplantation Applying Streptamer Technology

Falk Heidenreich, PhD, Elke Rücker-Braun, PhD, Sebastian Tuve, MD, Marc Schmitz, MD, Rebekka Wehner, PhD, Antje Tunger, Marcus Odendahl, PhD, Tonn Torsten, MD, Martin Bornhäuser, MD, Johannes Schetelig, MD, M. Sc, Cornelia S. Link, MD

Blood (2013) 122 (21): 5493.

https://doi.org/10.1182/blood.V122.21.5493.5493

Published: 2013

Journal Articles

The canonical Wnt pathway shapes niches supportive of hematopoietic stem/progenitor cells

Michiko Ichii, Mark Barton Frank, Renato V. Iozzo, Paul W. Kincade

Blood (2012) 119 (7): 1683–1692.

https://doi.org/10.1182/blood-2011-07-369199

Published: 2012

Includes: Supplemental data

Journal Articles

Small Leucine Rich Proteoglycans as Novel Tumor Markers In Chronic Lymphocytic Leukemia

Eva Mikaelsson, Mahmood Jeddi-Tehrani, Sr., Anders Ã–Sterborg, MD, PhD, Fazel Shokri, Hodjattallah Rabbani, Håkan Mellstedt

Blood (2010) 116 (21): 694.

https://doi.org/10.1182/blood.V116.21.694.694

Published: 2010

Journal Articles

High Lymphoid Enhancer-Binding Factor-1 (LEF1) Expression Is Associated with ZAP70 Positivity, Requirement of Treatment, and Fibromodulin (FMOD) Expression In Chronic Lymphocytic Leukemia (CLL)

Felix Erdfelder, Simon Jonas Poll-Wolbeck, Iris Gehrke, Michael Hallek, Karl-Anton Kreuzer

Blood (2010) 116 (21): 1715.

https://doi.org/10.1182/blood.V116.21.1715.1715

Published: 2010

Journal Articles

Expression of the Transcription Factor Lymphoid Enhancer Binding Factor-1 (LEF-1) Is Correlated to Aberrantly Increased Fibromodulin Transcripts in Chronic Lymphocytic Leukemia (CLL).

Felix Erdfelder, Iris Gehrke, Rajesh Kumar Gandhirajan, Magdalena Hertweck, Regina Razavi, Julian Paesler, Alexandra Filipovich, Sabrina Uhrmacher, Simon Jonas Poll-Wolbeck, Michael Hallek, MD, Karl Anton Kreuzer, MD

Blood (2009) 114 (22): 4589.

https://doi.org/10.1182/blood.V114.22.4589.4589

Published: 2009

Journal Articles

Disruption of T Cell Suppression in Chronic Lymphocytic Leukemia by CD200 Blockade.

Christian P Pallasch, MD, Susanne Ulbrich, MD, Reinhild Brinker, Robert A Uger, PhD, Michael Hallek, MD, Clemens- Martin Wendtner, MD

Blood (2008) 112 (11): 2072.

https://doi.org/10.1182/blood.V112.11.2072.2072

Published: 2008

Journal Articles

Vaccination of B-CLL Patients with Autologous Dendritic Cells Results in Immunological and Clinical Responses.

Iwona Hus, MD, PhD, Michael Schmitt, MD, PhD, Jacek Tabarkiewicz, MD, PhD, Sebastian Radej, MD, Agnieszka Bojarska-Junak, PhD, Kamila Wojas, PhD, Anita Schmitt, MD, PhD, Krzysztof Giannopoulos, MD, PhD, Anna Dmoszynska, MD, PhD, Jacek Rolinski, MD, PhD

Blood (2007) 110 (11): 2052.

https://doi.org/10.1182/blood.V110.11.2052.2052

Published: 2007

Journal Articles

Prospective Identification and Characterization of Human Mesenchymal Stem Cell Subpopulations.

Ariane Tormin, MS, Jan C. Brune, MS, Åke Borg, PhD, Ulf Neumann, MD, Tor Olofsson, PhD, Roland Lauster, PhD, Sten-Eirik Jakobsen, MD, PhD, Stefan Scheding, MD

Blood (2006) 108 (11): 2559.

https://doi.org/10.1182/blood.V108.11.2559.2559

Published: 2006

Journal Articles

High Frequency of T Regulatory Cells in Patients with B-Cell Chronic Lymphocytic Leukemia (B-CLL) Is Decreased by Thalidomide and Fludarabine Treatment.

Krzysztof Giannopoulos, MD, PhD, Michael Schmitt, MD PhD, Paulina Wlasiuk, MS C, Malgorzata Kowal, MD PhD, Monika Podhorecka, MD PhD, Jacek Rolinski, Anna Dmoszynska

Blood (2006) 108 (11): 2108.

https://doi.org/10.1182/blood.V108.11.2108.2108

Published: 2006

Journal Articles

Baseline Nucleophosmin Status in Mutated(M) Versus Unmutated (U) Immunoglobulin B-CLL Is a Nuclear Reflection of Different Signal Transduction Physiology.

Jerina Boelens, MD, Wim Van den Berghe, PhD, Guy Haegeman, PhD, Ann Janssens, MD, Jan Philippe, MD, PhD, Fritz Offner, MD, PhD

Blood (2005) 106 (11): 5005.

https://doi.org/10.1182/blood.V106.11.5005.5005

Published: 2005

Journal Articles

Gene Expression Profiling of B-Lymphocyte and Plasma Cell Populations from Waldenström’s Macroglobulinemia. Comparison with Expression Patterns of the Same Cell-Counterparts from Other B-Cell Neoplasms.

Norma C. Gutierrez, MD, PhD, Enrique M. Ocio, MD, PhD, Patricia Maiso, BSc, Encarna Ferminan, PhD, Manuel Delgado, BSc, Ricardo Lopez-Perez, PhD, Maria L. Sanchez, BSc, Maria J. Arcos, MD, Maria J. Moro, MD, Jose M. Hernandez, MD, Alberto Orfao, MD, PhD, Ramon Garcia-Sanz, MD, PhD, Jesus M. Hernandez, MD, PhD, Jesus F. San Miguel, MD, PhD

Blood (2005) 106 (11): 503.

https://doi.org/10.1182/blood.V106.11.503.503

Published: 2005

Journal Articles

The Receptor for Hyaluronic Acid Mediated Motility (RHAMM/CD168) Is a Potential Target for Immunotherapy of Patients with B-Cell Chronic Lymphocytic Leukemia.

Krzysztof Giannopoulos, MD, Iwona Hus, PhD, Li Li, MD, Agnieszka Bojarska-Junak, PhD, Jochen Greiner, MD, Jacek Rolinski, PhD, Anna Dmoszynska, PhD, Hartmut Doehner, MD, Michael Schmitt, MD

Blood (2005) 106 (11): 53.

https://doi.org/10.1182/blood.V106.11.53.53

Published: 2005

Journal Articles

Transduction of CLL cells by CD40 ligand enhances an antigen-specific immune recognition by autologous T cells

Christine Mayr, David M. Kofler, Hildegard Büning, Dagmar Bund, Michael Hallek, Clemens-Martin Wendtner

Blood (2005) 106 (9): 3223–3226.

https://doi.org/10.1182/blood-2005-04-1742

Published: 2005

Journal Articles

Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma

Eva Mikaelsson, Amir Hossein Danesh-Manesh, Alfred Lüppert, Mahmood Jeddi-Tehrani, Mohammad-Reza Rezvany, Ramazan Ali Sharifian, Reza Safaie, Azam Roohi, Anders Österborg, Fazel Shokri, Håkan Mellstedt, Hodjattallah Rabbani

Blood (2005) 105 (12): 4828–4835.

https://doi.org/10.1182/blood-2004-10-3941

Published: 2005

Journal Articles

Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8 + autologous T lymphocytes

Christine Mayr, Dagmar Bund, Martin Schlee, Andreas Moosmann, David M. Kofler, Michael Hallek, Clemens-Martin Wendtner

Blood (2005) 105 (4): 1566–1573.

https://doi.org/10.1182/blood-2004-04-1233

Published: 2005

Journal Articles

Fibromodulin as a Novel Tumor-Associated Antigen (TAA) in Chronic Lymphocytic Leukemia (CLL) Which Allows Expansion of Specific CD8+ Autologous T Lymphocytes.

Christine Mayr, MD, Dagmar Bund, Martin Schlee, PhD, Andreas Moosmann, PhD, Michael Hallek, MD, Clemens Wendtner, MD

Blood (2004) 104 (11): 175.

https://doi.org/10.1182/blood.V104.11.175.175

Published: 2004

Journal Articles

Downregulating the Fibromodulin Gene by Short Interfering RNA Causes B-CLL Cell Death.

Aniruddha Choudhury, Ph.D., Katja Derkow, B.S., Eva Mikaelsson, B.S., Parviz Kokhaei, B.S, Anders Österborg, M.D., Ph.D., Hodjattallah Rabbani, Ph.D., Håkan Mellstedt, M.D., Ph.D.

Blood (2004) 104 (11): 176.

https://doi.org/10.1182/blood.V104.11.176.176

Published: 2004

NARROW

Screening For Anti-Leukemic CTLs After Allogeneic Hematopoietic Stem Cell Transplantation Applying Streptamer Technology

The canonical Wnt pathway shapes niches supportive of hematopoietic stem/progenitor cells

Small Leucine Rich Proteoglycans as Novel Tumor Markers In Chronic Lymphocytic Leukemia

High Lymphoid Enhancer-Binding Factor-1 (LEF1) Expression Is Associated with ZAP70 Positivity, Requirement of Treatment, and Fibromodulin (FMOD) Expression In Chronic Lymphocytic Leukemia (CLL)

Expression of the Transcription Factor Lymphoid Enhancer Binding Factor-1 (LEF-1) Is Correlated to Aberrantly Increased Fibromodulin Transcripts in Chronic Lymphocytic Leukemia (CLL).

Disruption of T Cell Suppression in Chronic Lymphocytic Leukemia by CD200 Blockade.

Vaccination of B-CLL Patients with Autologous Dendritic Cells Results in Immunological and Clinical Responses.

Prospective Identification and Characterization of Human Mesenchymal Stem Cell Subpopulations.

High Frequency of T Regulatory Cells in Patients with B-Cell Chronic Lymphocytic Leukemia (B-CLL) Is Decreased by Thalidomide and Fludarabine Treatment.

Baseline Nucleophosmin Status in Mutated(M) Versus Unmutated (U) Immunoglobulin B-CLL Is a Nuclear Reflection of Different Signal Transduction Physiology.

Gene Expression Profiling of B-Lymphocyte and Plasma Cell Populations from Waldenström’s Macroglobulinemia. Comparison with Expression Patterns of the Same Cell-Counterparts from Other B-Cell Neoplasms.

The Receptor for Hyaluronic Acid Mediated Motility (RHAMM/CD168) Is a Potential Target for Immunotherapy of Patients with B-Cell Chronic Lymphocytic Leukemia.

Transduction of CLL cells by CD40 ligand enhances an antigen-specific immune recognition by autologous T cells

Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma

Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8 + autologous T lymphocytes

Fibromodulin as a Novel Tumor-Associated Antigen (TAA) in Chronic Lymphocytic Leukemia (CLL) Which Allows Expansion of Specific CD8+ Autologous T Lymphocytes.

Downregulating the Fibromodulin Gene by Short Interfering RNA Causes B-CLL Cell Death.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only